Chandan Healthcare Share Price

Chandan Healthcare Limited established on September 03 2003 specializes in operating stateoftheart laboratories that offer comprehensive pathological investigations. The Company run a diagnostic network in North India with pathology and radiology testing services. Their services encompass biochemistry hematology histopathology microbiology and immunology. Additionally it provide an extensive array of radiology services including CT scans Xrays and MRIs. The Company commenced business by starting its first diagnostic centre in Indra Nagar Lucknow in 2003. Later it started the diagnostic centre in Dehradun in 2013. It has established a chain of Retail Pharmacies in Uttar Pradesh Uttarakhand and Delhi along with wholesale distribution to our retail outlets and hospitals. Operating in Lucknow Chandan Hospital Limited is a 300bed tertiary care MultiSuperspecialty Hospital that has quickly gained recognition as one of the leading hospitals in the region since its opening on October 1st 2018.As of August 31 2024 the Company has 1 flagship laboratory 7 central laboratories 26 satellite centres more than 300 collection centres and located across India with facilities in more than 15 cities and towns across Uttar Pradesh and more than 10 cities and towns in Uttarakhand. Out of various laboratories 8 are National Accreditation Board for Testing and Calibration Laboratories NABL accredited while three of the diagnostic centres have National Accreditation Board for Hospitals Healthcare Providers NABH accreditation.Apart from these the Company provide nearly 1118 tests across different specialties. These test menu includes 169 routine pathology tests covering basic biochemistry and hematology as well as 713 specialized pathology tests such as immohistopathology and molecular pathology and 236 radiology tests including basic xrays ultrasonography USG computed tomography CT magnetic resonance imaging MRI and specialized CT scans. Radiology facilities have 11 CT scanners and 4 MRI machines. Committed to accuracy and reliability the Company supports healthcare professionals and patients by delivering essential diagnostic services. The Company is planning an IPO aggregating upto 6899936 Equity Shares of Face Value of Rs 10 each comprising a Fresh Issue of 4600000 Equity Shares and 2299936 Equity Shares through Offer for Sale..

Revenue: ₹62.65Cr as on March 2025 (Q4 FY25)
Net Profit: ₹6.10Cr as on March 2025 (Q4 FY25)
Listing date: 17 Feb, 2025
Chairperson Name: Amar Singh